EMA publishes Guideline Draft on Validation of biotechnology-derived Products

Posted on

For the EMA, it was necessary to develop an independent guideline on the topic as – despite the existence of harmonised ICH documents – specific aspects of the validation of biotechnology-derived products have been missing. A draft is now available.

A draft is now available.

EMA publishes Guideline Draft on Validation of biotechnology-derived Products

 

 

Advertisements

2 thoughts on “EMA publishes Guideline Draft on Validation of biotechnology-derived Products

    DR ANTHONY MELVIN CRASTO Ph.D responded:
    May 8, 2014 at 3:35 am

    Reblogged this on New Drug Approvals.

    medchemnintabelle said:
    May 9, 2014 at 9:51 am

    Reblogged this on MedCheminAustralia.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s